asthma. Mild persistent asthma
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, asthmatic patients will receive standard treatment of asthma (based on asthma severity and according to the Global Initiative for Asthma
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Pediatric patients admitted to allergy subspecialized clinic of Akbar hospital 6-12 years old With mild persistant asthma based on Global Initiative for Asthma (GINA) 2019 guideline Informed consent of patient/caregiver
Exclusion criteria
Exclusion criteria: Patients with pulmunary infection Patients with underlying cardiac, hepatic, biliary, renal, or gastrointestinal diseases or allergic rhinitis Patients with smoker parents Patients taking anticoagolant or antiplatelet medications Patients with diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients' clinical signs score in asthma control questionnaire (c-ACT). Timepoint: At baseline and end of the study (end of the second month). Method of measurement: Asthma Control Questionnaire.;Maximal Mid-Expiratory Flow rate (MMEF25-75). Timepoint: At baseline and end of the study (end of the second month). Method of measurement: spirometry test.;Value of Forced expiratory volume in one second (FEV1). Timepoint: At baseline and end of the study (end of the second month). Method of measurement: spirometry test.;Value of Forced Vital Capacity (FVC). Timepoint: At baseline and end of the study (end of the second month). Method of measurement: spirometry test.;Ratio of Forced expiratory volume in one second (FEV1)/Value of Forced Vital Capacity (FVC). Timepoint: At baseline and end of the study (end of the second month). Method of measurement: spirometry test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZinat Heidari
Mashhad University of Medical Sciences
Outcome results
None listed